150 related articles for article (PubMed ID: 11003616)
21. Induction of thymocyte apoptosis by systemic administration of concanavalin A in mice: role of TNF-alpha, IFN-gamma and glucocorticoids.
Fayad R; Sennello JA; Kim SH; Pini M; Dinarello CA; Fantuzzi G
Eur J Immunol; 2005 Aug; 35(8):2304-12. PubMed ID: 16047339
[TBL] [Abstract][Full Text] [Related]
22. P-selectin mediates leukocyte rolling in concanavalin-A-induced hepatitis.
March S; Garcia-Pagán JC; Massaguer A; Pizcueta P; Panés J; Engel P; Bosch J
Liver Int; 2005 Oct; 25(5):1053-60. PubMed ID: 16162166
[TBL] [Abstract][Full Text] [Related]
23. The essential role of interferon-gamma during interleukin-12 therapy for murine transitional cell carcinoma of the bladder.
O'Donnell MA; Luo Y; Hunter SE; Chen X; Hayes LL; Clinton SK
J Urol; 2004 Mar; 171(3):1336-42. PubMed ID: 14767344
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Concanavalin a-Induced Murine Autoimmune Hepatitis Models.
Ye T; Wang T; Yang X; Fan X; Wen M; Shen Y; Xi X; Men R; Yang L
Cell Physiol Biochem; 2018; 46(3):1241-1251. PubMed ID: 29672295
[TBL] [Abstract][Full Text] [Related]
25. Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis.
Murray HW; Moreira AL; Lu CM; DeVecchio JL; Matsuhashi M; Ma X; Heinzel FP
J Infect Dis; 2003 Aug; 188(3):458-64. PubMed ID: 12870129
[TBL] [Abstract][Full Text] [Related]
26. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis.
Kawakami K; Kinjo Y; Yara S; Uezu K; Koguchi Y; Tohyama M; Azuma M; Takeda K; Akira S; Saito A
Infect Immun; 2001 Nov; 69(11):6643-50. PubMed ID: 11598033
[TBL] [Abstract][Full Text] [Related]
27. Experimental African trypanosomiasis: IFN-gamma mediates early mortality.
Shi M; Pan W; Tabel H
Eur J Immunol; 2003 Jan; 33(1):108-18. PubMed ID: 12594839
[TBL] [Abstract][Full Text] [Related]
28. Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni- bacterium acnes.
Romics L; Dolganiuc A; Velayudham A; Kodys K; Mandrekar P; Golenbock D; Kurt-Jones E; Szabo G
J Leukoc Biol; 2005 Dec; 78(6):1255-64. PubMed ID: 16204620
[TBL] [Abstract][Full Text] [Related]
29. Beraprost sodium, a prostacyclin (PGI) analogue, ameliorates concanavalin A-induced liver injury in mice.
Ohta S; Nakamuta M; Fukushima M; Kohjima M; Kotoh K; Enjoji M; Nawata H
Liver Int; 2005 Oct; 25(5):1061-8. PubMed ID: 16162167
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the activation profile of dendritic cells derived from the bone marrow of interleukin-12/interleukin-23-deficient mice.
Bastos KR; de Deus Vieira de Moraes L; Zago CA; Marinho CR; Russo M; Alvarez JM; D'Império Lima MR
Immunology; 2005 Apr; 114(4):499-506. PubMed ID: 15804287
[TBL] [Abstract][Full Text] [Related]
31. Concanavalin a injection activates intrahepatic innate immune cells to provoke an antitumor effect in murine liver.
Miyagi T; Takehara T; Tatsumi T; Suzuki T; Jinushi M; Kanazawa Y; Hiramatsu N; Kanto T; Tsuji S; Hori M; Hayashi N
Hepatology; 2004 Nov; 40(5):1190-6. PubMed ID: 15486936
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive immune cell analysis of human menstrual-blood-derived stem cells therapy to concanavalin A hepatitis.
Zhang F; Fan L; Liu Q; Tang S; Zhang S; Xiao L; Zhang L; Li Q; Maihemuti N; Li L
Front Immunol; 2022; 13():974387. PubMed ID: 36248904
[TBL] [Abstract][Full Text] [Related]
33. Multi-Omics Analysis Reveals the Protection of Gasdermin D in Concanavalin A-Induced Autoimmune Hepatitis.
Wang K; Wu W; Jiang X; Xia J; Lv L; Li S; Zhuge A; Wu Z; Wang Q; Wang S; Li L
Microbiol Spectr; 2022 Oct; 10(5):e0171722. PubMed ID: 35972273
[TBL] [Abstract][Full Text] [Related]
34. Impaired NK cell cytotoxicity by high level of interferon-gamma in concanavalin A-induced hepatitis.
Dong Z; Zhang C; Wei H; Sun R; Tian Z
Can J Physiol Pharmacol; 2005 Nov; 83(11):1045-53. PubMed ID: 16391713
[TBL] [Abstract][Full Text] [Related]
35. Mice deficient in hepatocyte-specific IL-1Ra show delayed resolution of concanavalin A-induced hepatitis.
Lamacchia C; Rodriguez E; Palmer G; Vesin C; Seemayer CA; Rubbia-Brandt L; Gabay C
Eur J Immunol; 2012 May; 42(5):1294-303. PubMed ID: 22539301
[TBL] [Abstract][Full Text] [Related]
36. Differential involvement of IL-6 in the early and late phase of 1-methylnicotinamide (MNA) release in Concanavalin A-induced hepatitis.
Sternak M; Jakubowski A; Czarnowska E; Slominska EM; Smolenski RT; Szafarz M; Walczak M; Sitek B; Wojcik T; Jasztal A; Kaminski K; Chlopicki S
Int Immunopharmacol; 2015 Sep; 28(1):105-14. PubMed ID: 25976094
[TBL] [Abstract][Full Text] [Related]
37. Adipose tissue derived stromal stem cell therapy in murine ConA-derived hepatitis is dependent on myeloid-lineage and CD4+ T-cell suppression.
Higashimoto M; Sakai Y; Takamura M; Usui S; Nasti A; Yoshida K; Seki A; Komura T; Honda M; Wada T; Furuichi K; Ochiya T; Kaneko S
Eur J Immunol; 2013 Nov; 43(11):2956-68. PubMed ID: 23934743
[TBL] [Abstract][Full Text] [Related]
38. [Protective role of γδ T cells in concanavalin A-induced liver injury].
Zhao N; Ni Y; Zhao L; Wu Z; Yin Z
Zhonghua Gan Zang Bing Za Zhi; 2014 Jan; 22(1):58-62. PubMed ID: 24721246
[TBL] [Abstract][Full Text] [Related]
39. The novel NO-donating compound GIT-27NO inhibits in vivo growth of human prostate cancer cells and prevents murine immunoinflammatory hepatitis.
Donia M; Mijatovic S; Maksimovic-Ivanic D; Miljkovic D; Mangano K; Tumino S; Biondi A; Basile F; Al-Abed Y; Stosic-Grujicic S; Nicoletti F
Eur J Pharmacol; 2009 Aug; 615(1-3):228-33. PubMed ID: 19446546
[TBL] [Abstract][Full Text] [Related]
40. Effects of the Japanese herbal medicine 'Inchinko-to' (TJ-135) on concanavalin A-induced hepatitis in mice.
Yamashiki M; Mase A; Arai I; Huang XX; Nobori T; Nishimura A; Sakaguchi S; Inoue K
Clin Sci (Lond); 2000 Nov; 99(5):421-31. PubMed ID: 11052923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
